IRIS
LLEO DE NALDA, Ana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.567
AS - Asia 5.023
EU - Europa 1.956
SA - Sud America 972
AF - Africa 262
Continente sconosciuto - Info sul continente non disponibili 241
OC - Oceania 11
AN - Antartide 1
Totale 17.033
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.365
SG - Singapore 2.923
CN - Cina 937
BR - Brasile 799
IT - Italia 640
VN - Vietnam 468
FI - Finlandia 286
IE - Irlanda 209
DE - Germania 173
NG - Nigeria 170
HK - Hong Kong 148
FR - Francia 128
GB - Regno Unito 111
CA - Canada 101
IN - India 97
SE - Svezia 94
NL - Olanda 80
AR - Argentina 66
BD - Bangladesh 60
AE - Emirati Arabi Uniti 53
TR - Turchia 50
MX - Messico 46
RU - Federazione Russa 44
IQ - Iraq 43
ID - Indonesia 31
BE - Belgio 29
PK - Pakistan 29
EC - Ecuador 27
ZA - Sudafrica 27
PH - Filippine 23
ES - Italia 21
PL - Polonia 21
UA - Ucraina 21
IL - Israele 20
JP - Giappone 20
MK - Macedonia 20
CL - Cile 19
CZ - Repubblica Ceca 17
CO - Colombia 15
MA - Marocco 15
VE - Venezuela 15
MY - Malesia 13
SA - Arabia Saudita 13
UZ - Uzbekistan 13
NP - Nepal 12
PY - Paraguay 12
ET - Etiopia 11
JO - Giordania 11
KZ - Kazakistan 10
AU - Australia 9
KE - Kenya 9
RO - Romania 9
TT - Trinidad e Tobago 9
AT - Austria 8
DZ - Algeria 8
BB - Barbados 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
EG - Egitto 7
KR - Corea 7
PE - Perù 7
UY - Uruguay 7
AZ - Azerbaigian 6
GR - Grecia 6
JM - Giamaica 6
OM - Oman 6
RS - Serbia 6
TN - Tunisia 6
IR - Iran 5
LT - Lituania 5
AL - Albania 4
CH - Svizzera 4
HN - Honduras 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
EU - Europa 3
GD - Grenada 3
HR - Croazia 3
KG - Kirghizistan 3
NO - Norvegia 3
PA - Panama 3
PT - Portogallo 3
AM - Armenia 2
DK - Danimarca 2
GE - Georgia 2
GP - Guadalupe 2
LB - Libano 2
LK - Sri Lanka 2
ML - Mali 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SN - Senegal 2
TW - Taiwan 2
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 16.775
Salva come PNG Salva come JPEG
Città #
Singapore 1.364
Chandler 957
Wilmington 835
Ashburn 577
Dallas 498
San Jose 450
The Dalles 413
Shanghai 365
San Mateo 313
Helsinki 284
New York 280
Council Bluffs 271
Milan 268
Ann Arbor 266
Beijing 245
Dublin 208
Boardman 189
Benin City 167
Princeton 161
Lawrence 156
Ho Chi Minh City 150
Hong Kong 141
Leawood 141
Los Angeles 127
Hanoi 126
Santa Clara 117
Paris 95
Rome 90
São Paulo 71
Woodbridge 71
Fairfield 70
Phoenix 69
Amsterdam 57
Buffalo 53
London 52
Seattle 47
Toronto 43
Brussels 29
Naples 29
Da Nang 27
Orem 27
Charlotte 26
Atlanta 25
Chennai 24
Chicago 24
Falkenstein 24
Baghdad 22
Brooklyn 22
Houston 22
San Diego 20
Miami 19
Columbus 18
Frankfurt am Main 18
Haiphong 18
Philadelphia 18
Pune 18
Brasília 17
Montreal 17
Munich 17
Redwood City 17
Rio de Janeiro 17
Turin 17
Abbiategrasso 16
Assago 16
Boston 16
Dhaka 16
Stockholm 16
Kocaeli 15
Tokyo 15
Warsaw 15
Belo Horizonte 14
Johannesburg 14
San Francisco 14
Figino 13
Mexico City 13
Norwalk 13
Tashkent 13
Campinas 12
Denver 12
Guayaquil 12
Porto Alegre 12
Brno 11
Guarulhos 11
Addis Ababa 10
Amman 10
Manchester 10
The Bronx 10
Biên Hòa 9
Buenos Aires 9
Cincinnati 9
Istanbul 9
Mauá 9
Newark 9
Skopje 9
Ankara 8
Dearborn 8
Kuala Lumpur 8
Las Vegas 8
Ninh Bình 8
Oxnard 8
Totale 10.759
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 225
BNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection? 192
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 147
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 145
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 143
A 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019 132
Comparative analysis of portal cell infiltrates in antimitochondrial autoantibody-positive versus antimitochondrial autoantibody-negative primary biliary cirrhosis 126
Antimitochondrial antibody heterogeneity and the xenobiotic etiology of primary biliary cirrhosis 122
Genetic associations in Italian primary sclerosing cholangitis : heterogeneity across Europe defines a critical role for HLA-C 121
Innate Immunity and Primary Biliary Cirrhosis 120
Apotopes and the biliary specificity of primary biliary cirrhosis 120
X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma 120
Mapping the human genetic architecture of COVID-19 120
The limitations and hidden gems of the epidemiology of primary biliary cirrhosis 119
COVID-19 and liver cancer clinical trials: not everything is lost 115
B cell depletion therapy exacerbates murine primary biliary cirrhosis 115
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma 114
The consequences of apoptosis in autoimmunity 113
Autophagy: highlighting a novel player in the autoimmunity scenario 113
Lights and Shadows on Fibrates as Second-Line Therapy of Primary Biliary Cholangitis 112
Clinical Outcomes in the Second versus First Pandemic Wave in Italy: Impact of Hospital Changes and Reorganization 111
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options 109
COVID-19 Digestive System Involvement and Clinical Outcomes in a Large Academic Hospital in Milan, Italy 107
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 107
Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine 106
Interferon α and its contribution to autoimmunity 106
Is autoimmunity a matter of sex? 106
Prevalence and clinical significance of intrahepatic cholangiocellular carcinoma with radiological enhancement pattern mimicking hepatocellular carcinoma 106
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis 102
The overlap syndrome between primary biliary cirrhosis and primary sclerosing cholangitis 102
The X chromosome and immune associated genes 101
High mortality in COVID-19 patients with mild respiratory disease 101
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 100
Epigenetic investigation of variably X chromosome inactivated genes in monozygotic female twins discordant for primary biliary cirrhosis 99
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 98
Genome-wide analysis of DNA methylation, copy number variation, and gene expression in monozygotic twins discordant for primary biliary cirrhosis 98
Biliary apotopes and antimitochondrial antibodies activate innate immune responses in primary biliary cirrhosis 98
Definition of human autoimmunity - autoantibodies versus autoimmune disease 97
Advances in pharmacotherapy for primary biliary cirrhosis 97
Apotopes and innate immune system: Novel players in the primary biliary cirrhosis scenario 97
Safety of vedolizumab in liver transplant recipients: A systematic review 97
Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry 97
Hepatitis C virus eradication with DAA and liver cancer recurrence: is the best the enemy of the good? 96
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C 96
Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature 95
The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review 94
Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma 94
Autoimmunity and Turner's syndrome 94
HLA Class II antigens associated with lupus nephritis in Italian SLE patients 93
Tumor-Infiltrating Lymphocytes and Macrophages in Intrahepatic Cholangiocellular Carcinoma. Impact on Prognosis after Complete Surgery 93
The risk of Liver Cancer in Autoimmune Liver Diseases 92
Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase 92
Human leukocyte antigen polymorphisms in Italian primary biliary cirrhosis : a multicenter study of 664 patients and 1992 healthy controls 92
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 92
An individualized algorithm to predict mortality in COVID-19 pneumonia: a machine learning based study 91
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases 91
Etiopathogenesis of primary biliary cirrhosis 91
Benign liver tumors: Diagnostics and treatment 91
Melatonin exerts by an autocrine loop antiproliferative effects in cholangiocarcinoma; its synthesis is reduced favoring cholangiocarcinoma growth 91
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 90
A second update on mapping the human genetic architecture of COVID-19 89
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 89
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy 89
Changes in the Epidemiology of Primary Biliary Cholangitis 89
Primary biliary cholangitis: a comprehensive overview. 88
Making sense of Autoantibodies in Cholestatic Liver Diseases 88
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antivirals 88
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study 88
Intrahepatic cholangiocellular carcinoma with radiological enhancement patterns mimicking hepatocellular carcinoma 88
Primary biliary cholangitis 88
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 87
Increased loss of the Y chromosome in peripheral blood cells in male patients with autoimmune thyroiditis 87
Peak inflammation in atherosclerosis, primary biliary cirrhosis and autoimmune arthritis is counter-intuitively associated with regulatory T cell enrichment 87
Antimitochondrial Antibodies: from Bench to Bedside 87
Y chromosome loss in male patients with primary biliary cirrhosis 86
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine 85
Implications of genome-wide association studies in novel therapeutics in primary biliary cirrhosis 85
Role of liver biopsy in hepatocellular carcinoma 85
Lymphoid infiltrate predicts prognosis of mass-forming intrahepatic cholangiocarcinoma undergoing complete liver resection 85
Identifying medical professionals at risk for in-hospital COVID-19 infection: a snapshot during a "tsunami" highlighting unexpected risks 85
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 84
Molecular and Immunological Characterization of Biliary Tract Cancers: A Paradigm Shift Towards a Personalized Medicine 84
Management of patients with autoimmune liver disease during COVID-19 pandemic 84
The X-Factor in Primary Biliary Cirrhosis: Monosomy X and Xenobiotics 83
Refining surgical therapy of liver cancer in cirrhosis: etiology makes the difference 83
Liver Injury Induced by Immune Checkpoint Inhibitors: An Affordable Risk of Cancer Therapy? 83
Is the outcome after hepatectomy for transitional hepatocholangiocarcinoma different from that of hepatocellular carcinoma and mass-forming cholangiocarcinoma? A case-matched analysis 83
Letter to the Editor: might denosumab fit in PBC treatment? 82
Primary biliary cirrhosis and autoimmune hepatitis: apotopes and epitopes 81
What gastroenterologists should know about SARS-CoV 2 vaccine: World Endoscopy Organization perspective 81
The immunological potential of galectin-1 and -3 80
Infermieristica clinica in medicina interna 80
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 80
Shotgun Proteomics: Identification of Unique Protein Profiles of Apoptotic Bodies From Biliary Epithelial Cells 78
Mediterranean diet and NAFLD: What we know and questions that still need to be answered 78
Genetics and epigenetics of primary biliary cirrhosis 78
Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario 78
Sarcopenia is common in patients with cirrhosis and unresectable HCC treated by transarterial embolization but is not associated with increased rates of complications 78
Evolving trends in female to male incidence and male mortality of primary biliary cholangitis 78
Geoepidemiology, Genetic and Environmental Risk Factors for PBC 78
Totale 9.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 106.459
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.459
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022803 0 10 15 178 8 11 22 109 89 92 201 68
2022/20232.567 349 128 244 319 234 221 13 187 459 205 162 46
2023/20241.616 120 146 347 73 46 220 118 99 34 32 133 248
2024/20252.514 55 51 22 60 61 317 224 254 349 566 275 280
2025/20266.652 900 410 504 602 199 255 1.781 327 389 417 326 542
2026/20271.311 650 661 0 0 0 0 0 0 0 0 0 0
Totale 17.033